GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galmed Pharmaceuticals Ltd (FRA:GPH) » Definitions » Cyclically Adjusted Book per Share

Galmed Pharmaceuticals (FRA:GPH) Cyclically Adjusted Book per Share : €694.70 (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Galmed Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Galmed Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2025 was €6.914. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €694.70 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Galmed Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was -14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-05-28), Galmed Pharmaceuticals's current stock price is €2.736. Galmed Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €694.70. Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.00.


Galmed Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Galmed Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galmed Pharmaceuticals Cyclically Adjusted Book per Share Chart

Galmed Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 345.18 368.67 322.96

Galmed Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 356.06 359.86 156.72 322.96 694.70

Competitive Comparison of Galmed Pharmaceuticals's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

Galmed Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Galmed Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=6.914/134.9266*134.9266
=6.914

Current CPI (Mar. 2025) = 134.9266.

Galmed Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201506 393.984 100.684 527.978
201509 360.129 100.392 484.015
201512 319.000 99.792 431.311
201603 258.968 100.470 347.781
201606 207.081 101.688 274.769
201609 206.522 101.861 273.562
201612 156.701 101.863 207.565
201703 114.103 102.862 149.671
201706 81.691 103.349 106.651
201709 77.183 104.136 100.005
201712 166.838 104.011 216.428
201803 137.888 105.290 176.701
201806 671.836 106.317 852.627
201809 664.709 106.507 842.078
201812 660.333 105.998 840.550
201903 642.402 107.251 808.174
201906 615.615 108.070 768.606
201909 600.855 108.329 748.378
201912 537.333 108.420 668.700
202003 491.644 108.902 609.136
202006 450.653 108.767 559.038
202009 386.051 109.815 474.330
202012 307.576 109.897 377.629
202103 320.029 111.754 386.387
202106 268.698 114.631 316.270
202109 230.396 115.734 268.603
202112 194.173 117.630 222.726
202203 159.165 121.301 177.044
202206 140.964 125.017 152.138
202209 113.614 125.227 122.415
202212 90.507 125.222 97.521
202303 79.993 127.348 84.754
202306 69.579 128.729 72.929
202309 43.617 129.860 45.319
202312 30.302 129.419 31.591
202403 23.425 131.776 23.985
202406 20.660 132.554 21.030
202409 11.023 133.029 11.180
202412 9.365 133.157 9.489
202503 6.914 134.927 6.914

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Galmed Pharmaceuticals  (FRA:GPH) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.736/694.70
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Galmed Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Galmed Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Galmed Pharmaceuticals Business Description

Industry
Traded in Other Exchanges
Address
16 Abba Hillel Road, Ramat Gan, ISR, 5250608
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

Galmed Pharmaceuticals Headlines

No Headlines